Oncomed Manufacturing A.S. (Czech Republic)

Oncomed Manufacturing A.S. operates as a pharmaceutical contract development and manufacturing organization focused on sterile injectable medicines, with specialization in high potent and anticancer products. Business segments and products include development and manufacturing of cytostatic and other high-potency injectable pharmaceuticals for clinical and commercial supply, including fill and finish services for advanced formulations and complex drug types, supported by end-to-end project execution from technology transfer and process development through aseptic manufacturing, packaging and quality release activities. The company also positions manufacturing solutions for innovative modalities requiring controlled handling and high-quality sterile production, supported by regulated quality systems and GMP-compliant operations. Geographic scope and reach is international, serving pharmaceutical partners and group customers with Czech-based manufacturing capabilities and global supply orientation. Key brands and assets include GMP-certified sterile manufacturing infrastructure, specialized containment and production technologies suitable for high-potency injectables, quality control and quality assurance systems, and integration into a broader pharmaceutical group environment enabling technical and commercial continuity. Strategic focus and positioning emphasize premium quality and compliance in sterile injectable manufacturing, scalability from clinical to commercial volumes, specialization in high-potency oncology-related products, and long-term partnership positioning as a reliable CDMO for regulated global markets.